In this work, the vascular endothelial growth factor (VEGF) siRNA was used to inhibit tumor proliferation in transgenic adenocarcinoma of the mouse prostate cell (TRAMP C1) tumor mice. Here, VEGFA is linked to adenocarcinoma.